NCT00000354View on ClinicalTrials.gov

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

July 31, 1996

Primary Completion Date

September 30, 1997

Study Completion Date

December 31, 1997

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Lofexidine

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH